Order results by:
| Issue | Title | |
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... switching to cladribine, 22 had previously received natalizumab, 5 had received ocrelizumab and only 1 had ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... of cladribine was calculated based on the body weight. Results. The average frequency of exacerbations per year ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... of 2.42 per year (34 exacerbations) received a full cycle of cladribine therapy. The patients ..." | ||
| Vol 14, No 1 (2022) | Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... Objective: to evaluate the efficacy and safety of cladribine tablets as a treatment for immune ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... therapy with cladribine tablets with an average frequency of exacerbations of 1.2 (62 exacerbations in 48 ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... neuroinflammatory and neurodegenerative components. The goal of therapy of MS is to reduce the risk of exacerbations ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... (MS), especially for highly active MS (HAMS), in which there are ≥2 exacerbations and corresponding ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... of exacerbations and disability. On calculating, the authors took into account the current standards for the out ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... teriflunomide in the treatment of MS in the Russian Federation (for 1 year) and second-line natalizumab ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... a consensus on the practical aspects of switching patients with HAMS from other DMDMS to cladribine tablets ..." | ||
| Vol 13, No 4 (2021) | Neuroprotective therapy in acute ischemic stroke | Abstract similar documents |
| A. A. Kulesh | ||
| "... , natalizumab, interleukin 1 receptors antagonists, cerebrolysin, and other drugs have been analyzed. Non-drug ..." | ||
| Vol 14, No 5 (2022) | Current view on the diagnosis and treatment of neuromyelitis optica spectrum disorders exacerbations | Abstract similar documents |
| V. S. Krasnov, L. N. Prakhova, N. A. Totolyan | ||
| "... ) are formed as a result of exacerbations, which are often life-threatening. Timely diagnosis and treatment ..." | ||
| Vol 4, No 2 (2012) | A change in the parameters of P300 evoked potentials in relation to the degree of exacerbation of pain syndrome | Abstract similar documents |
| A P Rachin, A A Averchenkova | ||
| Vol 16 (2024): (Suppl. 2) | Optimization of therapy in secondary progressive multiple sclerosis | Abstract similar documents |
| A. N. Boyko, S. K. Zyryanov, Ya. V. Vlasov | ||
| "... sclerosis (SPMS). The only drug that has proven its effectiveness in all types of SPMS (with exacerbations ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... progression can be recorded, is stated to be 3 months. The exacerbation-unaffected disability progression ..." | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... initially received glatiramer acetate as DMT, which led to exacerbations and an increase in neurological ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... MS (PPMS), secondary progressive MS (SPMS) and exacerbations, and highly active MS. Objective ..." | ||
| Vol 16 (2024): (Suppl. 2) | Neuromyelitis optica spectrum disorders in children | Abstract similar documents |
| N. F. Akhmetgaleeva, T. O. Simaniv, E. M. Yausheva, Yа. A. Saitova, O. V. Lyutov, M. A. Kutlubaev, K. Z. Bakhtiyarova | ||
| "... is paid to the pathogenetic treatment of exacerbations and targeted therapy to prevent exacerbations ..." | ||
| Vol 11, No 2 (2019) | Tobacco smoking dependence in patients with depressive spectrum mental disorders: clinical, pathogenetic, and therapeutic aspects | Abstract similar documents |
| O. I. Speranskaya, S. A. Trushchelev, Z. I. Storozheva | ||
| "... a gradual reduction in tobacco withdrawal syndrome and to prevent an exacerbation of comorbid depression. ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... that this drug is effective in treating both MS with exacerbations and primary progressive MS. Currently ..." | ||
| Vol 9, No 2 (2017) | Chronic cerebral ischemia, neuroplasticity, possibilities of therapy | Abstract similar documents |
| E. I. Chukanova, A. S. Chukanova | ||
| "... , progression, and risk of exacerbations in patients with chronic cerebral ischemia. ..." | ||
| Vol 2, No 4 (2010) | Osteoarthrosis or osteoarthritis? The name of the disease through the eyes of a practitioner | Abstract similar documents |
| N. A. Khitrov | ||
| "... characteristics of synovitis in OA. The author describes anti-inflammatory therapy for knee OA in an exacerbation ..." | ||
| Vol 3, No 2 (2011) | Medical psychosomatics. Apropros of one date | Abstract similar documents |
| M. Yu. Drobizhev, A. A. Ovchinnikov, K. Yu. Retyunskiy, S. V. Kikta | ||
| "... disorder and a somatic disease affect each other (provoke an exacerbation, aggravate their course ..." | ||
| Vol 10, No 2 (2018) | The clinical and psychological features of mental development in children with opsoclonus-myoclonus syndrome | Abstract similar documents |
| N. S. Burlakova, Yu. V. Mikadze, Yu. N. Fedorova, R. Ts. Bembeeva, E. S. Ilyina, N. N. Zavadenko | ||
| "... with opsoclonus-myoclonus syndrome (OMS) in relation to the number of exacerbations. Patients and methods ..." | ||
| Vol 2, No 2 (2010) | Vestibular vertigo in emergency neurology and cervical osteochondrosis | Abstract similar documents |
| T. S. Barykova, E. V. Fastakovskaya | ||
| "... of vertebral artery irritation during an exacerbation of cervical osteochondrosis. The «cerebral» level ..." | ||
| Vol 14, No 6 (2022) | On the use of chondroitin sulfate, glucosamine sulfate and undenatured type II collagen for back and limb pain and osteoarthritis | Abstract similar documents |
| O. A. Gromova, I. Y. Torshin, A. M. Lila | ||
| "... tissue of the joint, which affects the nerve terminals and leads to an exacerbation of pain symptoms ..." | ||
| Vol 4, No 3 (2012) | Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases | Abstract similar documents |
| Vladimir Ernstovich Medvedev | ||
| "... of psychotropic drugs and psychotherapy are shown to result in a reduction in the incidence of exacerbations ..." | ||
| Vol 15 (2023): (Suppl. 1) | Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD) | Abstract similar documents |
| T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko | ||
| "... of the central nervous system. They are characterized by periodic, unpredictable exacerbations that lead ..." | ||
| Vol 16, No 6 (2024) | Neuromyelitis optica spectrum disorders, terminology and therapeutic issues: amended consensus opinion | Abstract similar documents |
| V. S. Krasnov, Yu. V. Vlasov, E. P. Evdoshenko, D. S. Korobko, M. D. Matson, A. I. Nilov, A. A. Sokolova, N. A. Totolian, N. V Khachanova, M. V. Shumilina, M. V. Davydovskaya | ||
| "... for prescribing medications that prevent exacerbations in patients with NMOSD with AQP4-IgG aged 18 years ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... exacerbations without taking specific pathogenetic therapy or one exacerbation during taking MS disease ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... .59 years) were observed to have ES. The annual MS exacerbation rate was 1.2±1.19. Two MS patients were ..." | ||
| Vol 14, No 6 (2022) | Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy | Abstract similar documents |
| V. S. Krasnov, K. Z. Bakhtiyarova, E. P. Evdoshenko, D. S. Korobko, T. O. Simaniv, N. A. Totolyan, N. V. Khachanova, M. V. Shumilina, M. V. Davydovskaya | ||
| "... a therapeutic algorithm to prevent exacerbations in patients with NMOSD with serum IgG antibodies to aquaporin-4 ..." | ||
| Vol 12, No 6 (2020) | COVID-19 and mental health: challenges and first conclusions | Abstract similar documents |
| V. E. Medvedev, O. A. Dogotar | ||
| "... in the foci of infection. The manifestation or exacerbation of mental illness in turn contributes ..." | ||
| Vol 13, No 1 (2021) | Depression during the COVID-19 pandemic (analysis of clinical cases) | Abstract similar documents |
| I. Yu. Dorozhenok | ||
| "... . The multifactorial stressor effect of the COVID-19 pandemic has provoked an exacerbation of depression in a male ..." | ||
| Vol 9, No 4 (2017) | Neurological complications of alcoholism | Abstract similar documents |
| I. I. Nikiforov, M. M. Rakitin, A. G. Merkin, P. V. Aronov, G. P. Kostyuk, D. V. Savelyev, R. N. Isaev, A. V. Kazantsev, V. A. Priyatel, I. A. Nikiforov | ||
| "... pathological craving for alcohol. Neurological pathology in turn occurs with frequent exacerbations ..." | ||
| Vol 3, No 3 (2011) | Analysis of reasons for failed surgery treatment in patients with back pain | Abstract similar documents |
| M. S. Kokina, E. G. Filatova | ||
| "... exacerbation, the frequency of admissions, the presence of radicular syndrome, the size of intervertebral ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... progressive (with exacerbations) MS. The experts emphasized how promising the use of these drugs ..." | ||
| Vol 15 (2023): (Suppl. 1) | Neuromyelitis optic spectrum disorders (NMOSD): from pathogenesis to targeted therapy | Abstract similar documents |
| P. A. Zaitseva, A. N. Boyko | ||
| "... of pathogenetic treatment of NMOSD are discussed, which has two main directions: treatment of exacerbations ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... 1224141, rs9514827) with the progression rate and frequency of MS exacerbations. Patients and methods ..." | ||
| Vol 15, No 4 (2023) | Psychosomatic correlations in mentally ill and mentally healthy women with infertility | Abstract similar documents |
| A. O. Nikolaevskaya, N. A. Tyuvina, V. D. Morozova, E. P. Kesler | ||
| "... during the period of exacerbation of the disease, insufficient emotional response to menarche (p<0 ..." | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... NMOSD is presented. A 10-year-old boy had two exacerbations within four months against the background ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... .13 (p<0.05). No exacerbations of the disease were recorded during the TeleRBT period. Conclusion ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... administration, which has moderate efficacy in reducing clinical exacerbations of multiple sclerosis (MS), which ..." | ||
| Vol 14, No 3 (2022) | Acute and long-term neurological disorders in patients with coronavirus infection | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, A. A. Kulesh | ||
| "... or exacerbation of a comorbid disease, including primary headache, musculoskeletal pain in the neck and back ..." | ||
| Vol 12, No 5 (2020) | B vitamins and nonsteroidal anti-inflammatory drugs: the efficacy of the combination for nonspecific back pain | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... over NSAID monotherapy in the treatment of acute NBS and exacerbations of chronic NBS. The addition ..." | ||
| Vol 11, No 2S (2019): Спецвыпуск: боль в спине и конечностях | A patient with osteoarthritis out of a doctor's field of vision: how should joint pain be controlled within the concept of responsible self-treatment? | Abstract similar documents |
| A. E. Karateev | ||
| "... : to assess therapy results and disease exacerbations, to maintain muscle tone and the necessary level ..." | ||
| Vol 8, No 1 (2016) | Comparative clinical characteristics of depression in bipolar affective disorders types I and II | Abstract similar documents |
| N. A. Tyuvina, I. G. Korobkova | ||
| "... duration, but a higher frequency of exacerbations; a greater tendency for the continuum; a more marked ..." | ||
| Vol 8, No 1 (2016) | Multiple sclerosis-related fatigue and possibilities of its correction | Abstract similar documents |
| N. Yu. Lashch, A. N. Boiko | ||
| "... be the first symptom of an MS exacerbation. The genesis of fatigue in MS is not known with certainty ..." | ||
| Vol 10, No 2 (2018) | Acute nonspecific (musculoskeletal) low back pain Guidelines of the Russian Society for the Study of Pain (RSSP) | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, N. N. Yakhno, M. L. Kukushkin, M. V. Churyukanov, O. S. Davydov, V. A. Golovacheva, A. I. Isaikin, E. E. Achkasov, G. Yu. Evzikov, A. E. Karateev, F. A. Khabirov, V. A. Shirokov | ||
| "... a non-exacerbation period. ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| "... of MS exacerbations and to the slower development of irreversible neurological deficit. Glatiramer ..." | ||
| Vol 7, No 2 (2015) | Herpesvirus-associated central and peripheral nervous system involvement: two clinical cases | Abstract similar documents |
| T. E. Popova, N. A. Shnayder, M. M. Petrova, T. Ya. Nikolaeva, E. A. Kantimirova, N. V. Isaeva, V. A. Shnayder, Yu. S. Panina, A. V. Dyuzhakova, S. K. Dyuzhakov | ||
| "... is characterized by dysfunction of the limbic system and by a long-term course with exacerbations. CIDP ..." | ||
| Vol 14, No 5 (2022) | Impact of work and study during pandemic on the mental state of medical professionals | Abstract similar documents |
| V. E. Medvedev, O. A. Dogotar, N. Yu. Lyzlova | ||
| "... The COVID-19 pandemic is causing a heavy increase in the incidence of development/exacerbation ..." | ||
| Vol 14, No 6 (2022) | Mental disorders during the pandemic of a new coronavirus infection: causes and predisposing factors | Abstract similar documents |
| N. A. Tyuvina, V. O. Vysokova, E. N. Efremova, O. V. Lavrinenko | ||
| "... and the exacerbations of the condition in mentally ill patients, which relate to the predictors, causes and clinical ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... shown to have a positive effect on neuroinflammatory processes in the onset or exacerbation of cognitive ..." | ||
| Vol 12, No 5 (2020) | Neuropathic pain in rheumatoid arthritis | Abstract similar documents |
| E. S. Filatova, A. M. Lila, V. A. Parfenov | ||
| "... by central sensitization. Conclusion. In patients with a RA exacerbation, chronic pain syndrome is caused ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| "... Owing to the advent of current methods for the prevention of exacerbations of multiple sclerosis ..." | ||
| Vol 6, No 3 (2014) | A clinical case of pseudotumorous chronic parainfectious limbic encephalitis | Abstract similar documents |
| N. A. Shnaider, Yu. S. Panina, T. E. Popova | ||
| "... and a prolonged course with frequent exacerbations. There are two types of the course of the disease: latent ..." | ||
| Vol 6, No 3 (2014) | Combination treatment for acute non-specific low back pain | Abstract similar documents |
| A. E. Barulin, O. V. Kurushina, A. E. Puchkov | ||
| "... both acute pain syndromes and exacerbations of chronic low back pain and that additional non-drug ..." | ||
| Vol 6, No 4 (2014) | Somatization of anxiety disorders in the practice of a neurologist: Algorithms and approaches to differentiated treatment | Abstract similar documents |
| E. G. Mendelevich | ||
| "... irreplaceable as an emergency care on an exacerbation of anxiety and exceptional therapeutic orientation ..." | ||
| Vol 15, No 3 (2023) | Impact of depression on the quality of life of patients with multiple sclerosis | Abstract similar documents |
| N. V. Zarubina, N. N. Spirin | ||
| "... and exacerbations (p<0.001). MS patients with depression significantly more often (p<0.01) complained of increased ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... of the combination of diphenhydramine + naproxen (NOVEMA® NIGHT) in patients with acute pain syndrome or exacerbation ..." | ||
| Vol 16 (2024): (Suppl. 2) | Pain in patients with neuromyelitis optica spectrum disorders | Abstract similar documents |
| E. S. Novikova, A. S. Kotov, S. V. Kotov | ||
| "... of the central nervous system with a relapsing course. Unfortunately, the symptoms of exacerbation cannot always ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... receiving curcumin, the proportion of patients with exacerbations over 6 months also decreased – from 45 ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... .2), in contrast to the comparison group, which showed increased disability (p=0.03). Hazard ratio for exacerbation ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... , a decrease in the concentration of this miRNA was noted in the group with exacerbations, from which ..." | ||
| 1 - 65 of 65 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
